To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants

NCT00420745 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1009

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL: Rotarix™
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline